Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
JAMA Oncology|September 30, 2018
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical TrialErminia Massarelli, William William, Faye Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Tae Beom Kim, Bo Peng, et al.
Research Square|June 29, 2026
Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinationsMinying Zhang, Barbara Nassif Rausseo, Peixin Jiang, et al.
Cancers|May 28, 2022
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung AdenocarcinomaJohannes F Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 13, 2022
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinomaRunzhe Chen, Jun Li, Junya Fujimoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic SignificanceYan Zhu, Luisa Maren Solis Soto, Shubham Pant, et al.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Nature Communications|August 8, 2018
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Nature Communications|January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Frontiers in Oncology|April 10, 2023
Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancersKenneth E Huffman, Long Shan Li, Ryan Carstens, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
JAMA Oncology|September 30, 2018
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical TrialErminia Massarelli, William William, Faye Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2017
Sarcomatoid Renal Cell Carcinoma Has a Distinct Molecular Pathogenesis, Driver Mutation Profile, and Transcriptional LandscapeZixing Wang, Tae Beom Kim, Bo Peng, et al.
Research Square|June 29, 2026
Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinationsMinying Zhang, Barbara Nassif Rausseo, Peixin Jiang, et al.
Cancers|May 28, 2022
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung AdenocarcinomaJohannes F Fahrmann, Ichidai Tanaka, Ehsan Irajizad, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 13, 2022
Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinomaRunzhe Chen, Jun Li, Junya Fujimoto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 20, 2025
Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic SignificanceYan Zhu, Luisa Maren Solis Soto, Shubham Pant, et al.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Nature Communications|August 8, 2018
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Nature Communications|January 31, 2019
Author Correction: Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancerJingying Nong, Yuhua Gong, Yanfang Guan, et al.
Frontiers in Oncology|April 10, 2023
Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancersKenneth E Huffman, Long Shan Li, Ryan Carstens, et al.
Pageof 13